AA-57-FZ47_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, (4-(Cyclopentylamino)-2-(methylthio)pyrimidin-5-yl)methanol, CDK Inhibitors targeting CCND2, CCND3 (Novartis, 10752510)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/10752510
Similar Terms
Downloads & Tools

Genes

18 genes differentially expressed following the AA-57-FZ47_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RPLP1 ribosomal protein, large, P1 0.455018
TMSB10 thymosin beta 10 0.36362
RPL39 ribosomal protein L39 0.36362
RPS29 ribosomal protein S29 0.299121
SF3B5 splicing factor 3b, subunit 5, 10kDa 0.293119

decreased expression

Symbol Name Standardized Value
RPL11 ribosomal protein L11 -1.45175
LRRC37B leucine rich repeat containing 37B -1.10976
RXYLT1 ribitol xylosyltransferase 1 -0.855353
SF3B6 splicing factor 3b, subunit 6, 14kDa -0.529534
RPS14 ribosomal protein S14 -0.408034
PMEPA1 prostate transmembrane protein, androgen induced 1 -0.40589
PPDPF pancreatic progenitor cell differentiation and proliferation factor -0.389106
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha -0.354168
TRIM56 tripartite motif containing 56 -0.265247
TENM3 teneurin transmembrane protein 3 -0.253416
SLC35A2 solute carrier family 35 (UDP-galactose transporter), member A2 -0.224636
DCD dermcidin -0.217183
ZNF688 zinc finger protein 688 -0.206437